Every round on record, with the sources behind each and the investors on them.
An AI platform for evaluating and developing drugs based on peptides
peptaris.comLinkedInBiotech3 people
Published on thinner evidence: weigh the verdict and its sources before you rely on it.
The $250,000 is Penn’s StartUP investment, not the full seed round; the article separately says Peptaris raised $4 million from investors in June.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Seed seed investment Published on thinner evidence, 1 source | $250K | ~ 2026-09-24 | not stated | No recent discussion |
[ VERIFIED ]0.57 Published on thinner evidence: weigh the verdict and its sources before you rely on it. read against 1 source The $250,000 is Penn’s StartUP investment, not the full seed round; the article separately says Peptaris raised $4 million from investors in June. [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search: "seed round" funding announcement startup | ||||
Peptaris builds an AI platform that mines biological information to discover, design, optimize, and develop peptide medicines for therapeutic use.
Checked against 8 sources today
Via Alexandria from Apollo: headcount, LinkedIn
None named.